N. S. Majhail, Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation, Hematology/Oncology and Stem Cell Therapy, vol.5, issue.1, pp.1-30, 2012.
DOI : 10.5144/1658-3876.2012.1

I. Martin, The Survey on Cellular and Engineered Tissue Therapies in Europe in 2009, Tissue Engineering Part A, vol.17, issue.17-18, pp.2221-2230, 2011.
DOI : 10.1089/ten.tea.2011.0131

G. Dighiero and T. J. Hamblin, Chronic lymphocytic leukaemia, The Lancet, vol.371, issue.9617, pp.1017-1029, 2008.
DOI : 10.1016/S0140-6736(08)60456-0

URL : https://hal.archives-ouvertes.fr/pasteur-00838819

A. C. Rawstron, Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia, New England Journal of Medicine, vol.359, issue.6, pp.575-583, 2008.
DOI : 10.1056/NEJMoa075290

A. Tefferi, Myelofibrosis with Myeloid Metaplasia, New England Journal of Medicine, vol.342, issue.17, pp.1255-1265, 2000.
DOI : 10.1056/NEJM200004273421706

D. M. Oliansky, The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the, 2001.

K. S. Peggs, S. Mackinnon, and D. C. Linch, The role of allogeneic transplantation in non-Hodgkin's lymphoma, British Journal of Haematology, vol.14, issue.1, pp.153-168, 2005.
DOI : 10.1002/cncr.11238

K. W. Van-besien, Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect, Bone Marrow Transplantation, vol.19, issue.10, pp.977-982, 1997.
DOI : 10.1038/sj.bmt.1700781

E. &. Forcade, . Meunier, C. Mathieu, and . Martin, Allogreffe de cellules souches hématopoïétiques Partie 1, Hematologie, vol.19, pp.288-296, 2013.

. Agence-de-la-biomédecine, Rapport annuel 2012 de l'Agence de la biomédecine, 2013.

M. Michallet, Allogreffes de cellules souches h??matopo????tiques, Transfusion Clinique et Biologique, vol.18, issue.2, pp.235-245, 2011.
DOI : 10.1016/j.tracli.2011.02.021

M. M. Horowitz, Graft-versus-leukemia reactions after bone marrow transplantation, Blood, vol.75, pp.555-562, 1990.

O. Ringden, Is there a graft-versus-leukaemia effect in the absence of graft-versushost disease in patients undergoing bone marrow transplantation for acute leukaemia?, British journal of haematology, vol.111, pp.1130-1137, 2000.

D. Maraninchi, IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS, The Lancet, vol.330, issue.8552, pp.175-178, 1987.
DOI : 10.1016/S0140-6736(87)90763-X

D. Blaise, Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis, The Lancet, vol.345, issue.8958, pp.1144-1146, 1995.
DOI : 10.1016/S0140-6736(95)90978-8

R. Storb, Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation, Journal of Clinical Oncology, vol.31, issue.12, pp.1530-1538, 2013.
DOI : 10.1200/JCO.2012.45.0247

D. Weisdorf, Graft-versus-Host Disease Induced Graft-versus-Leukemia Effect: Greater Impact on Relapse and Disease-Free Survival after Reduced Intensity Conditioning, Biology of Blood and Marrow Transplantation, vol.18, issue.11, pp.1727-1733, 2012.
DOI : 10.1016/j.bbmt.2012.06.014

F. Baron, Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation, Leukemia, vol.11, issue.12, pp.2462-2468, 2012.
DOI : 10.1056/NEJMoa1108188

O. Ringdén, The Highest Leukaemia-Free Survival After Allogeneic Bone Marrow Transplantation is Seen in Patients with Grade I Acute Graft-Versus-Host Disease, Leukemia & Lymphoma, vol.83, issue.1-2, pp.71-79, 1996.
DOI : 10.1111/j.1365-2141.1995.tb08356.x

J. L. Ferrara, J. E. Levine, P. Reddy, and E. Holler, Graft-versus-host disease, The Lancet, vol.373, issue.9674, pp.1550-1561, 2009.
DOI : 10.1016/S0140-6736(09)60237-3

J. Cahn, Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study, Blood, vol.106, issue.4, pp.1495-1500, 2005.
DOI : 10.1182/blood-2004-11-4557

A. Xhaard, Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine??Treatment, Biology of Blood and Marrow Transplantation, vol.18, issue.3, pp.406-413, 2012.
DOI : 10.1016/j.bbmt.2011.06.012

E. Goulmy, Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow Transplantation, New England Journal of Medicine, vol.334, issue.5, pp.281-285, 1996.
DOI : 10.1056/NEJM199602013340501

M. Bleakley and S. R. Riddell, Molecules and mechanisms of the graft-versus-leukaemia effect, Nature Reviews Cancer, vol.4, issue.5, pp.371-380, 2004.
DOI : 10.1038/nrc1365

T. Teshima, Acute graft-versus-host disease does not require alloantigen expression on host epithelium, Nature Medicine, vol.8, issue.6, pp.575-581, 2002.
DOI : 10.1038/nm0602-575

S. W. Choi, Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival, Blood, vol.112, issue.4, pp.1539-1542, 2008.
DOI : 10.1182/blood-2008-02-138867

K. L. Csencsits and D. K. Bishop, Contrasting Alloreactive CD4+ and CD8+ T Cells: There's More to It Than MHC Restriction, American Journal of Transplantation, vol.168, issue.2, pp.107-115, 2003.
DOI : 10.1084/jem.186.1.47

L. A. Welniak, B. R. Blazar, and W. J. Murphy, Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation, Annual Review of Immunology, vol.25, issue.1, pp.139-170, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141606

S. J. Lee, Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse, Blood, vol.100, issue.2, pp.406-414, 2002.
DOI : 10.1182/blood.V100.2.406

A. H. Filipovich, National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report, Biology of Blood and Marrow Transplantation, vol.11, issue.12, pp.945-956, 2005.
DOI : 10.1016/j.bbmt.2005.09.004

E. Tivol, Emergent autoimmunity in graft-versus-host disease, Blood, vol.105, issue.12, pp.4885-4891, 2005.
DOI : 10.1182/blood-2004-12-4980

O. Grauer, Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease, Brain, vol.133, issue.10, pp.2852-2865, 2010.
DOI : 10.1093/brain/awq245

Y. Sakoda, Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease, Blood, vol.109, issue.4, pp.1756-1764, 2007.
DOI : 10.1182/blood-2006-08-042853

F. T. Hakim, Age-dependent incidence, time course, and consequences of thymic renewal in adults, Journal of Clinical Investigation, vol.115, issue.4, pp.930-939, 2005.
DOI : 10.1172/JCI200522492

W. D. Shlomchik, S. J. Lee, D. Couriel, and S. Z. Pavletic, Transplantation???s Greatest Challenges: Advances in Chronic Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.13, pp.2-10, 2007.
DOI : 10.1016/j.bbmt.2006.10.020

M. E. Flowers, Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria, Blood, vol.117, issue.11, pp.3214-3219, 2011.
DOI : 10.1182/blood-2010-08-302109

D. S. Game and R. I. Lechler, Pathways of allorecognition: implications for transplantation tolerance, Transplant Immunology, vol.10, issue.2-3, pp.101-108, 2002.
DOI : 10.1016/S0966-3274(02)00055-2

A. Kumar, Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review, Leukemia, vol.119, issue.4, pp.582-588, 2012.
DOI : 10.1016/j.jclinepi.2007.03.013

A. Bacigalupo, Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation, Biology of Blood and Marrow Transplantation, vol.12, issue.5, pp.560-565, 2006.
DOI : 10.1016/j.bbmt.2005.12.034

D. Brabander, C. Cornelissen, J. Smitt, P. A. Vecht, C. J. Van-den-bent et al., Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors, Journal of Neurology, Neurosurgery & Psychiatry, vol.68, issue.1, pp.36-40, 2000.
DOI : 10.1136/jnnp.68.1.36

A. A. Pruitt, F. Graus, and M. R. Rosenfeld, Neurological Complications of Transplantation, The Neurohospitalist, vol.114, issue.15, pp.24-38, 2013.
DOI : 10.1177/1941874412455338

R. H. Herzig, Cerebellar toxicity with high-dose cytosine arabinoside., Journal of Clinical Oncology, vol.5, issue.6, pp.927-932, 1987.
DOI : 10.1200/JCO.1987.5.6.927

S. F. Dunton, R. Nitschke, W. E. Spruce, J. Bodensteiner, and H. Krous, Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A pediatric oncology group study, Cancer, vol.1, issue.6, pp.1083-1088, 1986.
DOI : 10.1002/1097-0142(19860315)57:6<1083::AID-CNCR2820570602>3.0.CO;2-B

K. L. Syrjala, S. Dikmen, S. L. Langer, S. Roth-roemer, and J. R. Abrams, Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant, Blood, vol.104, issue.10, pp.3386-3392, 2004.
DOI : 10.1182/blood-2004-03-1155

K. L. Syrjala, Prospective Neurocognitive Function Over 5 Years After Allogeneic Hematopoietic Cell Transplantation for Cancer Survivors Compared With Matched Controls at 5 Years, Journal of Clinical Oncology, vol.29, issue.17, pp.2397-2404, 2011.
DOI : 10.1200/JCO.2010.33.9119

P. Sostak, Cerebral angiitis in four patients with chronic GVHD, Bone Marrow Transplantation, vol.173, issue.7, pp.1181-1188, 2010.
DOI : 10.1111/j.1346-8138.2007.00263.x

Y. Matsuo, Encephalomyelitis Mimicking Multiple Sclerosis Associated with Chronic Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation, Internal Medicine, vol.48, issue.16, pp.1453-1456, 2009.
DOI : 10.2169/internalmedicine.48.2003

A. M. Delios, M. Rosenblum, A. A. Jakubowski, and L. M. Deangelis, Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease, Journal of Neuro-Oncology, vol.10, issue.5, pp.251-256, 2012.
DOI : 10.1007/s11060-012-0962-9

A. Paisiou, Acute disseminated encephalomyelitis after allogeneic bone marrow transplantation for pure red cell aplasia - A case report and review of the literature, Pediatric Transplantation, vol.54, issue.Pt 1, pp.41-45, 2013.
DOI : 10.1111/petr.12018

A. Tomonari, Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia, Ann. Hematol, vol.82, pp.37-40, 2003.

P. Woodard, Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis, Bone Marrow Transplantation, vol.33, issue.11, pp.1151-1157, 2004.
DOI : 10.1038/sj.bmt.1704480

R. Kumar, S. Nijalingappa, J. Grainger, and O. Ismayl, Acute disseminated encephalomyelitis mimicking late CNS relapse of acute lymphoblastic leukaemia: case report, Journal of Medical Case Reports, vol.22, issue.9, 2007.
DOI : 10.1038/sj.bmt.1701437

C. Solaro, A. Murialdo, D. Giunti, G. Mancardi, and A. Uccelli, Central and peripheral nervous system complications following allogeneic bone marrow transplantation, European Journal of Neurology, vol.49, issue.1, pp.77-80, 2001.
DOI : 10.1084/jem.158.1.1

M. Sakai, Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation, International Journal of Hematology, vol.84, issue.3, pp.272-275, 2006.
DOI : 10.1532/IJH97.06060

M. Vo\s-s and F. Bischof, Recurrent myelitis after allogeneic stem cell transplantation Report of two cases, BMC neurology, vol.10, p.76, 2010.

H. Openshaw, N. E. Slatkin, P. M. Parker, and S. J. Forman, Immune-mediated myelopathy after allogeneic marrow transplantation, Bone Marrow Transplant, vol.15, pp.633-636, 1995.

M. Bitan, Early???Onset Guillain???Barr?? Syndrome Associated with Reactivation of Epstein???Barr Virus Infection after Nonmyeloablative Stem Cell Transplantation, Clinical Infectious Diseases, vol.39, issue.7, pp.1076-1078, 2004.
DOI : 10.1086/424015

C. Karam, Immune-mediated neuropathies following stem cell transplantation, Journal of Neurology, Neurosurgery & Psychiatry, vol.14, issue.6, pp.638-642, 2014.
DOI : 10.1136/jnnp-2013-306657

V. Rodriguez, I. Kuehnle, H. E. Heslop, S. Khan, and R. A. Krance, Guillain???Barr?? syndrome after allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplantation, vol.29, issue.6, pp.515-517, 2002.
DOI : 10.1038/sj.bmt.1703412

P. Y. Wen, Guillain-Barre syndrome following allogeneic bone marrow transplantation, Neurology, vol.49, issue.6, pp.1711-1714, 1997.
DOI : 10.1212/WNL.49.6.1711

J. J. Griggs, C. S. Commichau, A. P. Rapoport, and R. C. Griggs, Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin's lymphoma, American Journal of Hematology, vol.23, issue.4, pp.332-334, 1997.
DOI : 10.1002/(SICI)1096-8652(199704)54:4<332::AID-AJH14>3.0.CO;2-D

P. J. Lorenzoni, Chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: case report, Arquivos de Neuro-Psiquiatria, vol.65, issue.3a, pp.700-704, 2007.
DOI : 10.1590/S0004-282X2007000400031

A. Tichelli, Late complications after hematopoietic stem cell transplantation, Expert Review of Hematology, vol.2, issue.5, pp.583-601, 2009.
DOI : 10.1586/ehm.09.48

H. Openshaw, N. E. Slatkin, A. S. Stein, D. R. Hinton, and S. J. Forman, Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia, Cancer, vol.4, issue.9, pp.1899-1905, 1996.
DOI : 10.1002/(SICI)1097-0142(19961101)78:9<1899::AID-CNCR9>3.0.CO;2-A

M. Odaka, Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barre syndrome, Brain, vol.126, issue.10, pp.2279-2290, 2003.
DOI : 10.1093/brain/awg233

T. R. Spitzer, Engraftment syndrome following hematopoietic stem cell transplantation, Bone Marrow Transplantation, vol.27, issue.9, pp.893-898, 2001.
DOI : 10.1038/sj.bmt.1703015

L. Chang, Engraftment Syndrome after Allogeneic Hematopoietic Cell Transplantation Predicts Poor Outcomes, Biology of Blood and Marrow Transplantation, vol.20, issue.9, pp.1407-1417, 2014.
DOI : 10.1016/j.bbmt.2014.05.022

URL : http://doi.org/10.1016/j.bbmt.2014.05.022

A. K. Omer, Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults, American Journal of Hematology, vol.109, issue.7, pp.698-705, 2014.
DOI : 10.1002/ajh.23716

M. Dimopoulos, Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma, New England Journal of Medicine, vol.357, issue.21, pp.2123-2132, 2007.
DOI : 10.1056/NEJMoa070594

D. M. Weber, Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America, New England Journal of Medicine, vol.357, issue.21, pp.2133-2142, 2007.
DOI : 10.1056/NEJMoa070596

A. A. Chanan-khan, Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ???65??years old with relapsed or refractory multiple myeloma, International Journal of Hematology, vol.25, issue.2, pp.254-262, 2012.
DOI : 10.1007/s12185-012-1125-7

N. T. Johnson, S. W. Crawford, and M. Sargur, Acute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation, Bone Marrow Transplant, vol.2, pp.203-207, 1987.

G. Lauria, D. Pareyson, M. Grisoli, and A. Sghirlanzoni, Clinical and magnetic resonance imaging findings in chronic sensory ganglionopathies, Annals of Neurology, vol.65, issue.1, pp.104-109, 2000.
DOI : 10.1002/1531-8249(200001)47:1<104::AID-ANA17>3.0.CO;2-X

N. Collongues, Cadre nosologique et strat??gie diagnostique de la my??lite aigu?? transverse longitudinalement ??tendue, Revue Neurologique, vol.170, issue.1, pp.6-12, 2014.
DOI : 10.1016/j.neurol.2013.04.008

M. Shintaku, N. Toyooka, T. Koyama, S. Teraoka, and M. Tsudo, Methotrexate myelopathy with extensive transverse necrosis: Report of an autopsy case, Neuropathology, vol.43, issue.Suppl. 35, 2014.
DOI : 10.1111/neup.12135

W. F. Hickey and H. Kimura, Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system., Proceedings of the National Academy of Sciences, vol.84, issue.7, pp.2082-2086, 1987.
DOI : 10.1073/pnas.84.7.2082

A. G. Saad, E. P. Alyea, P. Y. Wen, U. Degirolami, and S. Kesari, Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation, Journal of Clinical Oncology, vol.27, issue.30, pp.147-149, 2009.
DOI : 10.1200/JCO.2009.21.7919

S. Fuji, M. Kapp, and H. Einsele, Possible Implication of Bacterial Infection in Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation, Frontiers in Oncology, vol.38, issue.2, 2014.
DOI : 10.1016/j.leukres.2013.10.024

P. A. Van-doorn, L. Ruts, and B. Jacobs, Clinical features, pathogenesis, and treatment of Guillain-Barr?? syndrome, The Lancet Neurology, vol.7, issue.10, pp.939-950, 2008.
DOI : 10.1016/S1474-4422(08)70215-1

C. Kamm and U. K. Zettl, Autoimmune disorders affecting both the central and peripheral nervous system, Autoimmunity Reviews, vol.11, issue.3, pp.196-202, 2012.
DOI : 10.1016/j.autrev.2011.05.012

J. Lin, Risk Factors and Outcomes of Guillain-Barr?? Syndrome with Acute Myelitis, Pediatric Neurology, vol.44, issue.2, pp.110-116, 2011.
DOI : 10.1016/j.pediatrneurol.2010.08.013

S. Eliashiv, Acute inflammatory demyelinating polyneuropathy following bone marrow transplantation, Bone Marrow Transplant, vol.8, pp.315-317, 1991.

A. Perry, J. Mehta, T. Iveson, J. Treleaven, and R. Powles, Guillain-Barré syndrome after bone marrow transplantation, Bone Marrow Transplant, vol.14, pp.165-167, 1994.

W. Liedtke, K. Quabeck, D. W. Beelen, V. Straeten, and U. W. Schaefer, Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation, Journal of the Neurological Sciences, vol.125, issue.1, pp.110-111, 1994.
DOI : 10.1016/0022-510X(94)90250-X

M. Carozzi, A. De-manzini, A. Giorgi, and A. Osbich, Acute inflammatory polyradiculoneuritis during bone marrow transplantation. A report of 2 cases], Pediatr Med Chir, vol.16, pp.163-165, 1994.

M. E. Hagensee, M. Benyunes, J. A. Miller, and D. H. Spach, Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT, Bone Marrow Transplant, vol.13, pp.349-351, 1994.

J. Hernández-boluda, Guillain-Barre syndrome associated with cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation, Transplant Infectious Disease, vol.62, issue.2, pp.93-96, 2005.
DOI : 10.1182/blood.V97.4.867

B. Nasilowska-adamska, Guillain-Barre syndrome--pathological connection with GvHD after allogeneic bone marrow transplantation, Ann. Transplant, vol.11, pp.10-11, 2006.

F. Ostronoff, M. Perales, M. D. Stubblefield, and K. C. Hsu, Rituximab-responsive Guillain???Barr?? syndrome following allogeneic hematopoietic SCT, Bone Marrow Transplantation, vol.108, issue.1, pp.71-72, 2008.
DOI : 10.1038/bmt.2008.81

J. Thöne, S. Lamprecht, A. Hohaus, F. Erbguth, and A. Bickel, Guillain-Barr?? Syndrome as leading manifestation of Graft-versus-Host Disease in an allogeneic bone marrow transplanted patient, Journal of the Neurological Sciences, vol.292, issue.1-2, pp.114-116, 2010.
DOI : 10.1016/j.jns.2010.01.020

C. Adams, C. S. August, H. Maguire, and J. Sladky, Neuromuscular complications of bone marrow transplantation, Pediatric Neurology, vol.12, issue.1, pp.58-61, 1995.
DOI : 10.1016/0887-8994(94)00097-L

A. A. Amato, R. J. Barohn, Z. Sahenk, P. J. Tutschka, and J. Mendell, Polyneuropathy complicating bone marrow and solid organ transplantation, Neurology, vol.43, issue.8, pp.1513-1518, 1993.
DOI : 10.1212/WNL.43.8.1513

T. Nagashima, Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation, Neuropathology, vol.69, issue.Suppl. 13, pp.1-8, 2002.
DOI : 10.1046/j.0919-6544.2002.00419_22_1.x

S. Suzuki, Immune-mediated motor polyneuropathy after hematopoietic stem cell transplantation, Bone Marrow Transplantation, vol.45, issue.3, pp.289-291, 2007.
DOI : 10.1038/sj.bmt.1705716

Y. Doi, Immune-mediated peripheral neuropathy occurring simultaneously with recurrent graft-versus-host disease after allogenic hematopoietic stem cell transplantation, Leukemia Research, vol.36, issue.4, pp.63-65, 2012.
DOI : 10.1016/j.leukres.2011.11.025

W. Y. Au, Acute Disseminated Encephalomyelitis After Para-influenza Infection Post Bone Marrow Transplantation, Leukemia & Lymphoma, vol.210, issue.1, pp.455-457, 2002.
DOI : 10.1080/10428190290006350